Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

SRx Health Solutions (SRXH) Free Cash Flow (2016 - 2025)

SRx Health Solutions' Free Cash Flow history spans 16 years, with the latest figure at -$15.7 million for Q2 2025.

For Q2 2025, Free Cash Flow fell 446.48% year-over-year to -$15.7 million; the TTM value through Sep 2025 reached -$13.9 million, down 171.51%, while the annual FY2023 figure was $79000.0, 100.38% up from the prior year.
Free Cash Flow reached -$15.7 million in Q2 2025 per SRXH's latest filing, down from $377000.0 in the prior quarter.
In the past five years, Free Cash Flow ranged from a high of $1.5 million in Q4 2024 to a low of -$15.7 million in Q2 2025.
Average Free Cash Flow over 5 years is -$2.9 million, with a median of -$2.4 million recorded in 2021.
Peak YoY movement for Free Cash Flow: skyrocketed 138.09% in 2023, then crashed 1320.76% in 2024.
A 5-year view of Free Cash Flow shows it stood at -$3.8 million in 2021, then soared by 31.48% to -$2.6 million in 2022, then surged by 138.09% to $983000.0 in 2023, then surged by 48.83% to $1.5 million in 2024, then tumbled by 1176.14% to -$15.7 million in 2025.
Per Business Quant, the three most recent readings for SRXH's Free Cash Flow are -$15.7 million (Q2 2025), $377000.0 (Q1 2025), and $1.5 million (Q4 2024).